May 22, 2019 / 5:24 AM / a month ago

BRIEF-Novartis Presents Phase II Data For Combination Asthma Treatment

May 22 (Reuters) - Novartis AG:

* NOVARTIS PHASE II DATA FOR NEW INHALED COMBINATION TREATMENT (QVM149) DEMONSTRATES SIGNIFICANT IMPROVEMENTS OVER CURRENT STANDARD-OF-CARE INHALED TREATMENT Source text for Eikon: Further company coverage: (Berlin Speed Desk)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below